Agilent Technologies, Inc. $A Shares Sold by Magnetar Financial LLC

Magnetar Financial LLC lowered its holdings in shares of Agilent Technologies, Inc. (NYSE:A) by 32.1% during the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 67,240 shares of the medical research company’s stock after selling 31,820 shares during the period. Magnetar Financial LLC’s holdings in Agilent Technologies were worth $7,935,000 as of its most recent SEC filing.

Other institutional investors also recently added to or reduced their stakes in the company. Stone House Investment Management LLC acquired a new position in shares of Agilent Technologies during the first quarter valued at $30,000. Ransom Advisory Ltd bought a new position in Agilent Technologies in the 1st quarter valued at about $32,000. Central Pacific Bank Trust Division bought a new position in Agilent Technologies in the 2nd quarter valued at about $33,000. Zions Bancorporation National Association UT acquired a new position in Agilent Technologies during the 1st quarter valued at about $38,000. Finally, Costello Asset Management INC bought a new stake in shares of Agilent Technologies during the 1st quarter worth about $47,000. Institutional investors and hedge funds own 87.41% of the company’s stock.

Insider Activity at Agilent Technologies

In other news, CEO Padraig Mcdonnell sold 911 shares of Agilent Technologies stock in a transaction on Tuesday, November 18th. The stock was sold at an average price of $143.24, for a total transaction of $130,491.64. Following the transaction, the chief executive officer owned 32,058 shares in the company, valued at approximately $4,591,987.92. The trade was a 2.76% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. 0.26% of the stock is currently owned by company insiders.

Analyst Ratings Changes

A has been the subject of several research analyst reports. JPMorgan Chase & Co. upped their price objective on Agilent Technologies from $155.00 to $165.00 and gave the company an “overweight” rating in a report on Thursday, October 9th. TD Cowen raised their price objective on shares of Agilent Technologies from $150.00 to $162.00 and gave the company a “buy” rating in a research report on Tuesday, October 14th. Rothschild Redb upgraded shares of Agilent Technologies to a “strong-buy” rating in a report on Wednesday, October 8th. Weiss Ratings reissued a “hold (c)” rating on shares of Agilent Technologies in a research note on Wednesday, October 8th. Finally, UBS Group upgraded shares of Agilent Technologies from a “neutral” rating to a “buy” rating and raised their target price for the stock from $130.00 to $170.00 in a report on Wednesday, October 8th. One analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating and six have given a Hold rating to the company’s stock. Based on data from MarketBeat.com, Agilent Technologies currently has an average rating of “Moderate Buy” and a consensus price target of $149.62.

Agilent Technologies Price Performance

A stock opened at $151.49 on Friday. Agilent Technologies, Inc. has a one year low of $96.43 and a one year high of $153.84. The firm has a 50-day moving average of $139.65 and a two-hundred day moving average of $125.10. The firm has a market capitalization of $42.95 billion, a PE ratio of 35.56, a P/E/G ratio of 4.67 and a beta of 1.29. The company has a current ratio of 2.25, a quick ratio of 1.71 and a debt-to-equity ratio of 0.53.

Agilent Technologies (NYSE:A) last released its quarterly earnings results on Wednesday, August 27th. The medical research company reported $1.37 earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of $1.37. The business had revenue of $1.74 billion for the quarter, compared to analyst estimates of $1.67 billion. Agilent Technologies had a net margin of 17.97% and a return on equity of 25.51%. The firm’s revenue was up 10.1% compared to the same quarter last year. During the same quarter in the previous year, the business earned $1.32 earnings per share. Agilent Technologies has set its FY 2025 guidance at 5.560-5.590 EPS. Q4 2025 guidance at 1.570-1.600 EPS. On average, analysts forecast that Agilent Technologies, Inc. will post 5.58 earnings per share for the current year.

Agilent Technologies Increases Dividend

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, January 28th. Stockholders of record on Tuesday, January 6th will be given a $0.255 dividend. This represents a $1.02 annualized dividend and a dividend yield of 0.7%. This is a boost from Agilent Technologies’s previous quarterly dividend of $0.25. The ex-dividend date of this dividend is Tuesday, January 6th. Agilent Technologies’s payout ratio is 23.94%.

Agilent Technologies Company Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.